Margarita Abi Zeid Daou1, Brian D Boyd1, Manus J Donahue2, Kimberly Albert1, Warren D Taylor3. 1. The Center for Cognitive Medicine, Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN 37212, USA. 2. The Department of Radiology, Vanderbilt University Medical Center, Nashville, TN 37212, USA. 3. The Center for Cognitive Medicine, Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN 37212, USA; Geriatric Research, Education and Clinical Center, Department of Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN 37212, USA. Electronic address: warren.d.taylor@vanderbilt.edu.
Abstract
BACKGROUND: Vascular pathology is common in late-life depression (LLD) and may contribute to alterations in cerebral blood flow (CBF) and cerebrovascular reactivity (CVR). In turn, such hemodynamic deficits may adversely affect brain function and clinical course. The goal of this study was to examine whether altered cerebral hemodynamics in depressed elders predicted antidepressant response. METHODS: 21 depressed elders completed cranial 3T MRI, including a pseudo-continuous Arterial Spin Labeling (pcASL) acquisition on both room air and during a hypercapnia challenge. Participants then completed 12 weeks of open-label sertraline. Statistical analyses examined the relationship between regional normalized CBF and CVR values and change in Montgomery-Asberg Depression Rating Scale (MADRS) and tested for differences based on remission status. RESULTS: 10 participants remitted and 11 did not. After controlling for age and baseline MADRS, greater change in MADRS with treatment was associated with lower pre-treatment normalized CBF in the caudal anterior cingulate cortex (cACC) and lateral orbitofrontal cortex (OFC), as well as lower CVR with hypercapnia in the caudal medial frontal gyrus (cMFG). After controlling for age and baseline MADRS score, remitters exhibited lower CBF in the cACC and lower CVR in the cMFG. LIMITATIONS: Our sample was small, did not include a placebo arm, and we examined only specific regions of interest. CONCLUSIONS: Our findings suggest that increased perfusion of the OFC and the ACC is associated with a poor antidepressant response. They do not support that vascular pathology as measured by CBF and CVR negatively affects acute treatment outcomes. Published by Elsevier B.V.
BACKGROUND: Vascular pathology is common in late-life depression (LLD) and may contribute to alterations in cerebral blood flow (CBF) and cerebrovascular reactivity (CVR). In turn, such hemodynamic deficits may adversely affect brain function and clinical course. The goal of this study was to examine whether altered cerebral hemodynamics in depressed elders predicted antidepressant response. METHODS: 21 depressed elders completed cranial 3T MRI, including a pseudo-continuous Arterial Spin Labeling (pcASL) acquisition on both room air and during a hypercapnia challenge. Participants then completed 12 weeks of open-label sertraline. Statistical analyses examined the relationship between regional normalized CBF and CVR values and change in Montgomery-Asberg Depression Rating Scale (MADRS) and tested for differences based on remission status. RESULTS: 10 participants remitted and 11 did not. After controlling for age and baseline MADRS, greater change in MADRS with treatment was associated with lower pre-treatment normalized CBF in the caudal anterior cingulate cortex (cACC) and lateral orbitofrontal cortex (OFC), as well as lower CVR with hypercapnia in the caudal medial frontal gyrus (cMFG). After controlling for age and baseline MADRS score, remitters exhibited lower CBF in the cACC and lower CVR in the cMFG. LIMITATIONS: Our sample was small, did not include a placebo arm, and we examined only specific regions of interest. CONCLUSIONS: Our findings suggest that increased perfusion of the OFC and the ACC is associated with a poor antidepressant response. They do not support that vascular pathology as measured by CBF and CVR negatively affects acute treatment outcomes. Published by Elsevier B.V.
Authors: Manus J Donahue; Carlos C Faraco; Megan K Strother; Michael A Chappell; Swati Rane; Lindsey M Dethrage; Jeroen Hendrikse; Jeroen C W Siero Journal: J Cereb Blood Flow Metab Date: 2014-04-30 Impact factor: 6.200
Authors: Sean J Colloby; Michael J Firbank; Jiabao He; Alan J Thomas; Akshya Vasudev; Steve W Parry; John T O'Brien Journal: Br J Psychiatry Date: 2011-12-22 Impact factor: 9.319
Authors: Jason A Gandelman; Kimberly Albert; Brian D Boyd; Jung Woo Park; Meghan Riddle; Neil D Woodward; Hakmook Kang; Bennett A Landman; Warren D Taylor Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2018-09-21
Authors: Wenjing Wei; Helmet T Karim; Chemin Lin; Akiko Mizuno; Carmen Andreescu; Jordan F Karp; Charles F Reynolds; Howard J Aizenstein Journal: J Clin Psychiatry Date: 2018-10-23 Impact factor: 4.384
Authors: Margarita Abi Zeid Daou; Brian D Boyd; Manus J Donahue; Kimberly Albert; Warren D Taylor Journal: J Psychiatr Res Date: 2017-11-11 Impact factor: 4.791
Authors: Warren D Taylor; Brian D Boyd; Damian Elson; Patricia Andrews; Kimberly Albert; Jennifer Vega; Paul A Newhouse; Neil D Woodward; Hakmook Kang; Sepideh Shokouhi Journal: Am J Geriatr Psychiatry Date: 2020-09-28 Impact factor: 4.105
Authors: Ryan Ahmed; Claire Ryan; Seth Christman; Damian Elson; Camilo Bermudez; Bennett A Landman; Sarah M Szymkowicz; Brian D Boyd; Hakmook Kang; Warren D Taylor Journal: Am J Geriatr Psychiatry Date: 2021-11-28 Impact factor: 7.996
Authors: Emilie Sleight; Michael S Stringer; Ian Marshall; Joanna M Wardlaw; Michael J Thrippleton Journal: Front Physiol Date: 2021-02-25 Impact factor: 4.566